Cargando…

Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. Cancers 2022, 14, 5794

Detalles Bibliográficos
Autores principales:	Brosch, Philippa K., Korsa, Tessa, Taban, Danush, Eiring, Patrick, Kreisz, Philipp, Hildebrand, Sascha, Neubauer, Julia, Zimmermann, Heiko, Sauer, Markus, Shirakashi, Ryo, Djuzenova, Cholpon S., Sisario, Dmitri, Sukhorukov, Vladimir L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647605/ https://www.ncbi.nlm.nih.gov/pubmed/37958481 http://dx.doi.org/10.3390/cancers15215139

Ejemplares similares

Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration
por: Brosch, Philippa K., et al.
Publicado: (2022)

Contraction of the rigor actomyosin complex drives bulk hemoglobin expulsion from hemolyzing erythrocytes
por: Shirakashi, Ryo, et al.
Publicado: (2022)

Hypotonic Activation of the Myo-Inositol Transporter SLC5A3 in HEK293 Cells Probed by Cell Volumetry, Confocal and Super-Resolution Microscopy
por: Andronic, Joseph, et al.
Publicado: (2015)

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
por: Djuzenova, Cholpon S., et al.
Publicado: (2021)

FocAn: automated 3D analysis of DNA repair foci in image stacks acquired by confocal fluorescence microscopy
por: Memmel, Simon, et al.
Publicado: (2020)

Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells
por: Djuzenova, Cholpon S., et al.
Publicado: (2019)

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
por: Grabenbauer, Felix, et al.
Publicado: (2018)

SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia
por: Wei, Yiliang, et al.
Publicado: (2022)

Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis
por: De Paepe, Boel, et al.
Publicado: (2020)

Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities
por: Memmel, Simon, et al.
Publicado: (2017)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
por: Nachef, Marianna, et al.
Publicado: (2021)

Results of the Modified Brosch Approach and Rehabilitation of Mural Unicystic Ameloblastoma of the Mandible in a Young Patient
por: Subramani, Vijayanirmala, et al.
Publicado: (2023)

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth
por: Cui, Zihan, et al.
Publicado: (2022)

Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy
por: Damanskienė, Eligija, et al.
Publicado: (2022)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)

SLC-2000: a luminosity upgrade for the SLC
por: Breidenbach, M, et al.
Publicado: (1996)

Slc7a5 regulation of neural development
por: Sokolov, Aidan M., et al.
Publicado: (2021)

mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas
por: Suh, Sunghwan, et al.
Publicado: (2018)

Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma
por: Tina, E., et al.
Publicado: (2018)

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals
por: Le, MyPhuong T., et al.
Publicado: (2013)

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
por: Sniegowski, Tyler, et al.
Publicado: (2021)

The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse
por: Fernandez-Fuente, Gonzalo, et al.
Publicado: (2023)

Molecular Mechanisms of the SLC13A5 Gene Transcription
por: Li, Zhihui, et al.
Publicado: (2021)

Status of the SLC
por: Seeman, J T, et al.
Publicado: (1987)

Polarization at SLC
por: Swartz, M L
Publicado: (1988)

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder
por: Rodek, Patryk, et al.
Publicado: (2022)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Beam-beam simulations with non-gaussian distributions for SLC and SLC-2000
por: Bane, Karl Leopold Freitag, et al.
Publicado: (1998)

Novel mutations in SLC6A5 with benign course in hyperekplexia
por: Dafsari, Hormos Salimi, et al.
Publicado: (2019)

Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5
por: Chen, Fangfang, et al.
Publicado: (2023)

SLC5A3 is important for cervical cancer cell growth
por: Li, Li, et al.
Publicado: (2023)

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
por: Chen, Yan-Jie, et al.
Publicado: (2022)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Metabolic adaptations to hypoxia in the neonatal mouse forebrain can occur independently of the transporters SLC7A5 and SLC3A2
por: Fitzgerald, Eamon, et al.
Publicado: (2021)

Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation
por: Bouthelier, Antonio, et al.
Publicado: (2022)

Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule
por: Djuzenova, Cholpon S., et al.
Publicado: (2016)

Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization
por: Kuger, Sebastian, et al.
Publicado: (2015)

Stanford: Preparing for SLC
Publicado: (1983)

Stanford: SLC excitement
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_cuqoala7bfnbqidvsg1l0k3dj4